CDT Equity Announced That New Solid Forms And Alternative Crystal Structures Of Its Existing Drug Compounds, Show Enhanced Physical Property Advantages, Including Improved Stability, Solubility, Manufacturability, Over Existing Forms Of These Compounds

CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio

CDT Equity Inc. announced the development of new solid forms and crystal structures of its existing drug compounds with improved stability, solubility, and manufacturability. The company has filed patents for new therapeutic uses identified through AI-driven analysis, targeting underserved patient populations. CDT plans to advance these findings through laboratory models and pursue licensing partnerships, aiming to create a differentiated, patent-protected portfolio with reduced scientific risk.

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers Picard Medical (AMEX:PMI) shares moved upwards by 82.7% to $9.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.5 million. As per the news, the Q2 earnings report

CDT Equity Enters SAFE Note Investment In Pep'd, Expanding Exposure To Fast-Growing US Peptide Market With $10M Valuation Cap